FDEQX
Price
$80.95
Change
-$0.79 (-0.97%)
Updated
Aug 20 closing price
Net Assets
2.3B
RGAEX
Price
$86.79
Change
+$0.78 (+0.91%)
Updated
Aug 21 closing price
Net Assets
342.42B
Interact to see
Advertisement

FDEQX vs RGAEX

FDEQX vs RGAEX Comparison Chart in %
View a ticker or compare two or three
VS
FDEQX vs. RGAEX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FDEQX is a StrongBuy and RGAEX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGAEX has more cash in the bank: 342B vs. FDEQX (2.3B). RGAEX pays higher dividends than FDEQX: RGAEX (0.22) vs FDEQX (0.00). FDEQX was incepted earlier than RGAEX: FDEQX (38 years) vs RGAEX (24 years). FDEQX (0.66) and RGAEX (0.63) have similar cost to investors . FDEQX is a more actively managed with annual turnover of: 53.00 vs. RGAEX (32.00). FDEQX has a lower initial minimum investment than RGAEX: FDEQX (0) vs RGAEX (250). FDEQX annual gain was more profitable for investors over the last year : 9.41 vs. RGAEX (5.47). FDEQX return over 5 years is better than : 31.84 vs. RGAEX (16.97).
FDEQXRGAEXFDEQX / RGAEX
Total Expense Ratio0.660.63105%
Annual Report Gross Expense Ratio0.660.63105%
Fund Existence38 years24 years-
Gain YTD11.8259.404126%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets2.3B342B1%
Annual Yield % from dividends0.000.22-
Returns for 1 year9.415.47172%
Returns for 3 years47.8846.98102%
Returns for 5 years31.8416.97188%
Returns for 10 years145.92100.96145%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RNWEX108.151.60
+1.50%
American Funds New World R-4
CMJIX53.180.37
+0.70%
Calvert US Mid Cap Core Rspnb Idx I
PSSJX27.190.18
+0.67%
Principal SmallCap S&P 600 Index J
SVFCX99.570.66
+0.67%
Smead Value C
CRRVX10.78-0.01
-0.09%
Columbia Real Estate Equity Inst2